A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects

Clinical trial NCT05642377 · UNKNOWN

Trial details

NCT number: NCT05642377
Sponsor: Glaceum
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2022-11-22
Primary completion: 2024-07-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.